Jason R. Gotlib on JAK Inhibitors for the Treatment of MyelofibrosisByJason R. GotlibMarch 23rd 2016Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.
Jason R. Gotlib Discusses MPN Research at StanfordByJason R. GotlibDecember 22nd 2015Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.